[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[FYI] Foresight publishes nanotech guidelines
- To: debate@fitug.de
- Subject: [FYI] Foresight publishes nanotech guidelines
- From: "Ralf Stephan" <ralf@ark.in-berlin.de>
- Date: Sat, 17 Jun 2000 13:25:17 +0200
- Comment: This message comes from the debate mailing list.
- Mail-Followup-To: debate@fitug.de
- Reply-To: ralf@ark.in-berlin.de
- Sender: owner-debate@fitug.de
[Im Endeffekt läuft das nicht nur auf ähnliche Handhabung wie
Biotech hinaus (wo die Schutzbestimmungen bisher erfolgreich
waren), sondern erlaubt darüber hinausgehende Sicherheiten, d.h.
Nanotech-Handhabung wäre sicherer als Biotech jetzt, wenn auch
der GAU (gray goo) weitreichender.]
http://www.foresight.org/guidelines/pr001.html
http://www.foresight.org/guidelines/
http://www.foresight.org/hotnews/index.html#JoyWorries
...
Development Principles
1. Artificial replicators must not be capable of replication in a
natural, uncontrolled environment.
2. Evolution within the context of a self-replicating manufacturing
system is discouraged.
3. Any replicated information should be error free.
4. MNT device designs should specifically limit proliferation and
provide traceability of any replicating systems.
5. Developers should attempt to consider systematically the
environmental consequences of the technology, and to limit these
consequences to intended effects. This requires significant
research on environmental models, risk management, as well as the
theory, mechanisms, and experimental designs for built-in
safeguard systems.
6. Industry self-regulation should be designed in whenever possible.
Economic incentives could be provided through discounts on
insurance policies for MNT development organizations that certify
Guidelines compliance. Willingness to provide self-regulation
should be one condition for access to advanced forms of the
technology.
7. Distribution of molecular manufacturing development capability
should be restricted, whenever possible, to responsible actors
that have agreed to use the Guidelines. No such restriction need
apply to end products of the development process that satisfy the
Guidelines.
Specific Design Guidelines
1. Any self-replicating device which has sufficient onboard
information to describe its own manufacture should encrypt it such
that any replication error will randomize its blueprint.
2. Encrypted MNT device instruction sets should be utilized to
discourage irresponsible proliferation and piracy.
3. Mutation (autonomous and otherwise) outside of sealed laboratory
conditions, should be discouraged.
4. Replication systems should generate audit trails.
5. MNT device designs should incorporate provisions for built-in
safety mechanisms, such as: 1) absolute dependence on a single
artificial fuel source or artificial "vitamins" that don't exist
in any natural environment; 2) making devices that are dependent
on broadcast transmissions for replication or in some cases
operation; 3) routing control signal paths throughout a device, so
that subassemblies do not function independently; 4) programming
termination dates into devices, and 5) other innovations in
laboratory or device safety technology developed specifically to
address the potential dangers of MNT.
6. MNT developers should adopt systematic security measures to avoid
unplanned distribution of their designs and technical
capabilities.
...
ralf
--
http://ME.IN-berlin.de/~rws/
If there's a Web node with no links to it, is the node really there?